UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 36

Sortiert nach

Design of Potent and Selective Covalent Inhibitors of Bruton’s Tyrosine Kinase Targeting an Inactive Conformation

ACS medicinal chemistry letters, 2019-10, Vol.10 (10), p.1467-1472

2019

Link zum Volltext

Verfügbarkeit prüfen

N-aryl-piperidine-4-carboxamides as a novel class of potent inhibitors of MALT1 proteolytic activity

Bioorganic & medicinal chemistry letters, 2018-07, Vol.28 (12), p.2153-2158

2018

Link zum Volltext

Verfügbarkeit prüfen

Papaverine hydrochloride containing nanostructured lyotropic liquid crystal formulation as a potential drug delivery system for the treatment of erectile dysfunction

Drug design, development and therapy, 2018-01, Vol.12, p.2923-2931

2018

Link zum Volltext

Verfügbarkeit prüfen

Current advances in the synthesis and biological potencies of tri- and tetra-substituted 1H-imidazoles

Molecular diversity, 2015-08, Vol.19 (3), p.577-623

2015

Link zum Volltext

Verfügbarkeit prüfen

Imidazole derivatives show anticancer potential by inducing apoptosis and cellular senescence

MedChemComm, 2014-11, Vol.5 (11), p.1751-1760

2014

Link zum Volltext

Verfügbarkeit prüfen

Sucrose Esters Increase Drug Penetration, But Do Not Inhibit P‐Glycoprotein in Caco‐2 Intestinal Epithelial Cells

Journal of pharmaceutical sciences, 2014-10, Vol.103 (10), p.3107-3119

2014

Link zum Volltext

Verfügbarkeit prüfen

Plasticized Drug‐Loaded Melt Electrospun Polymer Mats: Characterization, Thermal Degradation, and Release Kinetics

Journal of pharmaceutical sciences, 2014-04, Vol.103 (4), p.1278-1287

2014

Link zum Volltext

Verfügbarkeit prüfen

Activation of the miR-17 family and miR-21 during murine kidney ischemia-reperfusion injury

Nucleic acid therapeutics, 2013-10, Vol.23 (5), p.344

2013

Link zum Volltext

Verfügbarkeit prüfen

p38 Mitogen-activated protein kinase inhibitors: a review on pharmacophore mapping and QSAR studies

Current topics in medicinal chemistry, 2013-05, Vol.13 (9), p.1015

2013

Link zum Volltext

Verfügbarkeit prüfen

Kinetic Analysis of the Toxicity of Pharmaceutical Excipients Cremophor EL and RH40 on Endothelial and Epithelial Cells

Journal of pharmaceutical sciences, 2013-04, Vol.102 (4), p.1173-1181

2013

Link zum Volltext

Verfügbarkeit prüfen

Medicinal Chemistry Approaches for the Inhibition of the p38 MAPK Pathway

Protein Kinases as Drug Targets, 2011, p.271-304

2011

Link zum Volltext

Verfügbarkeit prüfen

In vivo and in vitro SAR of tetracyclic MAPKAP-K2 (MK2) inhibitors. Part I

Bioorganic & medicinal chemistry letters, 2010-08, Vol.20 (15), p.4715-4718

2010

Link zum Volltext

Verfügbarkeit prüfen

In vivo and in vitro SAR of tetracyclic MAPKAP-K2 (MK2) inhibitors. Part II

Bioorganic & medicinal chemistry letters, 2010-08, Vol.20 (15), p.4719-4723

2010

Link zum Volltext

Verfügbarkeit prüfen

IKKβ inhibitors identification part II: Ligand and structure-based virtual screening

Bioorganic & medicinal chemistry, 2010-06, Vol.18 (11), p.3951-3960

2010

Link zum Volltext

Verfügbarkeit prüfen

Novel 3-aminopyrazole inhibitors of MK-2 discovered by scaffold hopping strategy

Bioorganic & medicinal chemistry letters, 2010-02, Vol.20 (3), p.1293-1297

2010

Link zum Volltext

Verfügbarkeit prüfen

Pyrrolo-pyrimidones : A novel class of MK2 inhibitors with potent cellular activity

Bioorganic & medicinal chemistry, 2008-12, Vol.18 (23), p.6142-6146

2008

Link zum Volltext

Verfügbarkeit prüfen

Pharmacophore modeling of diverse classes of p38 MAP kinase inhibitors

European journal of medicinal chemistry, 2008-12, Vol.43 (12), p.2870-2876

2008

Link zum Volltext

Verfügbarkeit prüfen

Are MAP Kinases Drug Targets? Yes, but Difficult Ones

ChemMedChem, 2007-08, Vol.2 (8), p.1116-1140

2007

Link zum Volltext

Verfügbarkeit prüfen

Substituted Isoxazoles as Potent Inhibitors of p38 MAP Kinase

ChemMedChem, 2006-02, Vol.1 (2), p.197-207

2006

Link zum Volltext

Verfügbarkeit prüfen

Pyrazoloheteroaryls: Novel p38α MAP kinase inhibiting scaffolds with oral activity

Bioorganic & medicinal chemistry letters, 2006-01, Vol.16 (2), p.262-266

2006

Link zum Volltext

Verfügbarkeit prüfen

Small molecular anti-cytokine agents

Medicinal research reviews, 2006-01, Vol.26 (1), p.1-62

2006

Link zum Volltext

Verfügbarkeit prüfen

Design and preparation of 2-benzamido-pyrimidines as inhibitors of IKK

Bioorganic & medicinal chemistry letters, 2006, Vol.16 (1), p.108-112

2006

Link zum Volltext

Verfügbarkeit prüfen

New approaches to the treatment of inflammatory disorders small molecule inhibitors of p38 MAP kinase

Current topics in medicinal chemistry, 2006, Vol.6 (2), p.113

2006

Link zum Volltext

Verfügbarkeit prüfen

Novel CCR1 antagonists with oral activity in the mouse collagen induced arthritis

Bioorganic & medicinal chemistry letters, 2005-12, Vol.15 (23), p.5160-5164

2005

Link zum Volltext

Verfügbarkeit prüfen

The discovery of novel chemotypes of p38 kinase inhibitors

Current topics in medicinal chemistry, 2005-09, Vol.5 (10), p.953

2005

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 36

Suche als RSS-Feed

Aktive Filter

ThemaChemistry, Medicinal

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(31)

Publikationsform

Artikel
(35)
Buchkapitel
(1)

Sprache

Englisch
(36)
Japanisch
(5)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Design of Potent and Selective Covalent Inhibitors of Bruton’s Tyrosine Kinase Targeting an Inactive Conformation

N-aryl-piperidine-4-carboxamides as a novel class of potent inhibitors of MALT1 proteolytic activity

Papaverine hydrochloride containing nanostructured lyotropic liquid crystal formulation as a potential drug delivery system for the treatment of erectile dysfunction

Current advances in the synthesis and biological potencies of tri- and tetra-substituted 1H-imidazoles

Imidazole derivatives show anticancer potential by inducing apoptosis and cellular senescence

Sucrose Esters Increase Drug Penetration, But Do Not Inhibit P‐Glycoprotein in Caco‐2 Intestinal Epithelial Cells

Plasticized Drug‐Loaded Melt Electrospun Polymer Mats: Characterization, Thermal Degradation, and Release Kinetics

Activation of the miR-17 family and miR-21 during murine kidney ischemia-reperfusion injury

p38 Mitogen-activated protein kinase inhibitors: a review on pharmacophore mapping and QSAR studies

Kinetic Analysis of the Toxicity of Pharmaceutical Excipients Cremophor EL and RH40 on Endothelial and Epithelial Cells

Medicinal Chemistry Approaches for the Inhibition of the p38 MAPK Pathway

In vivo and in vitro SAR of tetracyclic MAPKAP-K2 (MK2) inhibitors. Part I

In vivo and in vitro SAR of tetracyclic MAPKAP-K2 (MK2) inhibitors. Part II

IKKβ inhibitors identification part II: Ligand and structure-based virtual screening

Novel 3-aminopyrazole inhibitors of MK-2 discovered by scaffold hopping strategy

Pyrrolo-pyrimidones : A novel class of MK2 inhibitors with potent cellular activity

Pharmacophore modeling of diverse classes of p38 MAP kinase inhibitors

Are MAP Kinases Drug Targets? Yes, but Difficult Ones

Substituted Isoxazoles as Potent Inhibitors of p38 MAP Kinase

Pyrazoloheteroaryls: Novel p38α MAP kinase inhibiting scaffolds with oral activity

Small molecular anti-cytokine agents

Design and preparation of 2-benzamido-pyrimidines as inhibitors of IKK

New approaches to the treatment of inflammatory disorders small molecule inhibitors of p38 MAP kinase

Novel CCR1 antagonists with oral activity in the mouse collagen induced arthritis

The discovery of novel chemotypes of p38 kinase inhibitors

Aktive Filter

Suchergebnisse filtern